Globus Medical, Inc. (GMED)
Largest Insider Buys in Sector
GMED Stock Price History Chart
GMED Stock Performance
About Globus Medical, Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and …
Insider Activity of Globus Medical, Inc.
Over the last 12 months, insiders at Globus Medical, Inc. have bought $0 and sold $13.55M worth of Globus Medical, Inc. stock.
On average, over the past 5 years, insiders at Globus Medical, Inc. have bought $99,824 and sold $20.19M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 615 shares for transaction amount of $33,136 was made by Douglas Robert Andrew (director) on 2020‑08‑24.
List of Insider Buy and Sell Transactions, Globus Medical, Inc.
| 2024-10-16 | Sale | director | 50,000 0.0393% | $75.04 | $3.75M | -1.03% | ||
| 2024-10-16 | Sale | SVP, GC, Corporate Secretary | 7,500 0.0059% | $75.02 | $562,649 | -1.03% | ||
| 2024-09-13 | Sale | director | 25,000 0.0187% | $70.46 | $1.76M | +1.29% | ||
| 2024-09-13 | Sale | director | 15,000 0.0112% | $70.36 | $1.06M | +1.29% | ||
| 2024-07-11 | Sale | director | 1,000 0.0008% | $70.00 | $70,000 | 0.00% | ||
| 2024-05-10 | Sale | director | 63,300 0.0468% | $64.61 | $4.09M | +8.14% | ||
| 2024-05-08 | Sale | director | 20,000 0.0156% | $65.00 | $1.3M | +13.38% | ||
| 2024-03-15 | Sale | director | 10,590 0.0079% | $51.99 | $550,574 | +30.61% | ||
| 2024-03-01 | Sale | SVP, GC, Corporate Secretary | 7,500 0.0055% | $54.10 | $405,730 | +22.38% | ||
| 2023-05-15 | Sale | director | 43,450 0.0436% | $56.98 | $2.48M | -6.09% | ||
| 2023-02-02 | Sale | SVP, Chief Financial Officer | 29,167 0.0287% | $77.57 | $2.26M | -30.27% | ||
| 2022-12-01 | Sale | SVP, GC, Corporate Secretary | 7,500 0.0074% | $75.00 | $562,501 | -24.68% | ||
| 2022-04-19 | Sale | 31,500 0.031% | $78.03 | $2.46M | -20.94% | |||
| 2022-04-08 | Sale | SVP, GC, Corporate Secretary | 2,500 0.0025% | $75.58 | $188,963 | -17.58% | ||
| 2022-03-15 | Sale | 8,850 0.0087% | $65.47 | $579,418 | -2.35% | |||
| 2022-03-08 | Sale | 4,484 0.0045% | $72.00 | $322,848 | -7.13% | |||
| 2021-08-19 | Sale | SVP, Chief Financial Officer | 833 0.0008% | $76.13 | $63,416 | -11.03% | ||
| 2021-08-02 | Sale | SVP, Chief Financial Officer | 833 0.0008% | $83.24 | $69,339 | -15.73% | ||
| 2021-07-19 | Sale | SVP, Chief Financial Officer | 834 0.0008% | $78.25 | $65,261 | -9.40% | ||
| 2021-07-02 | Sale | EVP, Chief Commercial Officer | 100,000 0.0985% | $78.41 | $7.84M | -8.33% |
Insider Historical Profitability
| Douglas Robert Andrew | director | 2005 0.0015% | $82.22 | 3 | 0 | +25.46% |
Institutional Investor Ownership
| The Vanguard Group | $587.61M | 8.11 | 10.95M | -2.86% | -$17.33M | 0.01 | |
| BlackRock | $583.78M | 8.06 | 10.88M | +0.38% | +$2.22M | 0.01 | |
| Janus Henderson | $411.01M | 5.67 | 7.66M | -3.12% | -$13.22M | 0.21 | |
| State Street | $191.9M | 2.65 | 3.58M | +1.09% | +$2.07M | 0.01 | |
| Wellington Management Company | $174.32M | 2.41 | 3.25M | +11.58% | +$18.1M | 0.03 |